A prospective study of the effect of PFH (plasma free hemoglobin) on outcomes in ECMO patients

A prospective study of the effect of PFH (plasma free hemoglobin) on outcomes in ECMO patients - Effect of PFH on outcome in ECMO patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045790

Enrollment

150

Registered

2021-10-20

Start date

2021-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe respiratory failure, Severe heart failure, Cardiac arrest

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ECMO patients in ICU

Exclusion criteria

Exclusion criteria: Chronic dialysis patients, Patients with hematological disease

Design outcomes

Primary

Measure	Time frame
90-day mortality rate	—

Secondary

Measure	Time frame
ECMO equipment troubles, hemolysis and thrombosis	—

Countries

Japan

Contacts

Public ContactNatsumi Suga

Graduate School of Medicine, Chiba University Department of Emergency and Critical Care Medicine

natsumi_u_0809@yahoo.co.jp043-226-2341

Outcome results